INFUTREL
Live / Allowed — Fourth extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97677779
- Mark type
- Word mark
- Filed
- 15 Nov 2022
- Published for opposition
- 16 Jul 2024
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Trace elements for injection, namely, dietetic infusions for medical use containing copper, chromium, zinc, selenium, manganese, iron, iodine, fluoride and molybdenum for parenteral infusion
Owner
- Sandoz Canada Inc., Boucherville, Quebec, CA
- Sandoz Canada Inc., Boucherville, Quebec, CA
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 4 GRANTED
- 09 Sept 2026 — SOU EXTENSION 4 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 3 GRANTED
- 03 Mar 2026 — SOU EXTENSION 3 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2025 — SOU EXTENSION 2 GRANTED
- 06 Sept 2025 — SOU EXTENSION 2 FILED
- 06 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Mar 2025 — SOU EXTENSION 1 GRANTED
- 07 Mar 2025 — SOU EXTENSION 1 FILED